全球數位診斷市場

到 2030 年，全球數位診斷市場規模將達到 31 億美元

全球數位診斷市場規模預計在2024年達到12億美元，預計2024年至2030年期間的複合年成長率為18.0%，到2030年將達到31億美元。硬體組件是本報告分析的細分市場之一，預計其複合年成長率將達到17.5%，到分析期結束時規模將達到18億美元。軟體組件細分市場在分析期間內的複合年成長率預計為19.3%。

美國市場預計將達到 3.156 億美元，而中國市場預計將以 23.6% 的複合年成長率成長

美國數位診斷市場規模預計在2024年達到3.156億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到6.931億美元，在2024-2030年的分析期間內，複合年成長率為23.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為13.4%和16.2%。在歐洲，預計德國的複合年成長率約為14.3%。

全球數位診斷市場—主要趨勢與促進因素摘要

數位診斷將如何改變臨床測試和監測？

數位診斷將醫療檢測技術與數位平台結合，以改善疾病檢測、患者監測和決策。數位診斷透過互聯設備和軟體實現快速、分散的檢測，使醫療專業人員能夠遠端分析結果並即時共用見解。應用範圍涵蓋慢性病監測、傳染病篩檢、基因檢測和遠端病理。

透過數位系統獲得的診斷數據會自動儲存、分析，並通常整合到電子健康記錄中，從而提高一致性並減少診斷錯誤。家用檢測套組、基於智慧型手機的檢測和穿戴式健康監測儀為患者提供即時回饋，並減少對醫院基礎設施的依賴。這些解決方案也有助於農村地區的醫療保健服務和疫情應對規劃。

哪些技術正在提升數位診斷的能力？

生物感測器設計、微流體和微型化技術的進步，使得可攜式診斷設備達到實驗室級的精確度。透過藍牙、Wi-Fi和雲端系統實現的連接，實現了設備和醫療平台之間的持續資料傳輸。人工智慧演算法被用於放射學、病理學和皮膚病學的模式識別，從而提高了診斷速度和準確性。

分子診斷技術正在不斷發展，並與數位PCR系統整合，從而提高對低水平生物標記的靈敏度。機器學習也正應用於解讀基因組和蛋白質體數據，以實現個人化疾病分析。資料安全和加密框架確保了患者資料在各個平台的安全儲存和共用。總而言之，這些技術有助於實現更早的檢測、更快的結果取得和更完善的治療途徑。

數位診斷工具的採用在哪裡加速？

醫院和診斷實驗室正在採用數位化解決方案來簡化工作流程並管理更大的檢測量。初級保健診所正在使用快速診斷工具來縮短診斷時間並改善患者分診。糖尿病、心血管疾病和呼吸系統疾病的家用診斷套件在老齡化社會和行動不便的患者中越來越受歡迎。

製藥公司和臨床試驗營運商正在整合數位診斷技術，以實現遠端患者監護和即時數據收集。公共衛生部門正在疾病爆發期間部署行動診斷單元和數位監測工具。在資源匱乏的地區，數位診斷平台可在社區健康中心和偏遠村莊提供基本檢測，從而提高可及性和公平性。

哪些因素推動了數位診斷市場的成長？

數位診斷市場的成長受到與醫療保健服務模式、技術進步和人口結構相關的多種因素的推動。對慢性病和感染疾病的早期準確診斷的需求日益成長，推動了攜帶式和聯網檢測系統的普及。向分散式護理和遠端健康監測的轉變，為家用和行動診斷工具創造了強勁的市場。

醫療記錄的數位化和互通性正在推動診斷數據融入患者照護平台。感測器精度、設備便攜性與人工智慧主導分析的持續創新，持續提升診斷的可靠性。支持性報銷政策和政府對數位醫療基礎設施的投資，正在促進更廣泛的醫療服務可近性。隨著醫療保健系統向基於價值的醫療服務邁進，數位診斷在效率、病人參與和臨床場景的療效追蹤方面均取得了顯著的提升。

部分

組件（硬體組件、軟體組件、服務組件）；診斷類型（心臟病學診斷、腫瘤學診斷、神經病學診斷、放射學診斷、病理學診斷、其他診斷類型）；最終用戶（醫院/診所最終用戶、臨床實驗室最終用戶、其他最終用戶）

受訪公司範例

• Aidoc
• AliveCor Inc.
• Arterys Inc.
• Babylon Health
• Biofourmis
• Butterfly Network, Inc.
• Canon Medical Systems Corp.
• Digital Diagnostics Inc.
• GE HealthCare Technologies Inc.
• HeartFlow, Inc.
• iCAD Inc.
• Infermedica
• Lunit Inc.
• Medtronic plc
• Nanox Imaging Ltd.
• PathAI
• Philips Healthcare
• Qure.ai
• Siemens Healthineers AG
• Viz.ai

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Digital Diagnostics Market to Reach US$3.1 Billion by 2030

The global market for Digital Diagnostics estimated at US$1.2 Billion in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 18.0% over the analysis period 2024-2030. Hardware Component, one of the segments analyzed in the report, is expected to record a 17.5% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Software Component segment is estimated at 19.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$315.6 Million While China is Forecast to Grow at 23.6% CAGR

The Digital Diagnostics market in the U.S. is estimated at US$315.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$693.1 Million by the year 2030 trailing a CAGR of 23.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.4% and 16.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.3% CAGR.

Global Digital Diagnostics Market - Key Trends & Drivers Summarized

How Are Digital Diagnostics Transforming Clinical Testing and Monitoring?

Digital diagnostics combines medical testing technologies with digital platforms to improve disease detection, patient monitoring, and decision-making. It enables rapid, decentralized testing through connected devices and software, allowing healthcare professionals to analyze results remotely and share insights in real time. Applications range from chronic disease monitoring and infectious disease screening to genetic testing and telepathology.

Diagnostic data captured through digital systems is automatically stored, analyzed, and often integrated into electronic medical records. This improves consistency and reduces diagnostic errors. At-home testing kits, smartphone-based assays, and wearable health monitors provide patients with real-time feedback and reduce dependence on hospital infrastructure. These solutions are also instrumental in rural healthcare delivery and pandemic response planning.

Which Technologies Are Advancing Digital Diagnostics Capabilities?

Advances in biosensor design, microfluidics, and miniaturization have enabled portable diagnostic devices that deliver lab-grade accuracy. Connectivity through Bluetooth, Wi-Fi, and cloud systems allows continuous data transmission between devices and healthcare platforms. AI algorithms are used for pattern recognition in radiology, pathology, and dermatology, improving diagnostic speed and precision.

Molecular diagnostics is evolving through integration with digital PCR systems, enhancing sensitivity for low-concentration biomarkers. Machine learning is also applied to interpret genomic and proteomic data for personalized disease profiling. Data security and encryption frameworks ensure safe storage and sharing of patient data across platforms. These technologies collectively support a shift toward earlier detection, faster results, and improved care pathways.

Where Is the Adoption of Digital Diagnostic Tools Accelerating?

Hospitals and diagnostic laboratories are implementing digital solutions to streamline workflows and manage higher testing volumes. Primary care clinics use rapid diagnostic tools to reduce time to diagnosis and improve patient triage. In-home diagnostic kits for diabetes, cardiovascular conditions, and respiratory illnesses are gaining acceptance among aging populations and patients with mobility constraints.

Pharmaceutical companies and clinical trial operators are integrating digital diagnostics to enable remote patient monitoring and real-time data capture. Public health authorities deploy mobile diagnostic units and digital surveillance tools during disease outbreaks. In low-resource settings, digital diagnostic platforms enable basic testing in community health centers and remote villages, improving access and equity.

What Factors Are Driving Growth in the Digital Diagnostics Market?

Growth in the digital diagnostics market is driven by several factors related to healthcare delivery models, technology advancements, and population health trends. Rising demand for early, accurate diagnosis of chronic and infectious diseases has increased deployment of portable and connected testing systems. Shift toward decentralized care and remote health monitoring has created a strong market for home-based and mobile diagnostic tools.

Digitalization of healthcare records and interoperability mandates have supported integration of diagnostic data into patient care platforms. Ongoing innovation in sensor accuracy, device portability, and AI-driven analytics continues to improve diagnostic reliability. Supportive reimbursement policies and government investments in digital health infrastructure are facilitating broader access. As healthcare systems move toward value-based care, digital diagnostics offer measurable improvements in efficiency, patient engagement, and outcome tracking across varied clinical settings.

SCOPE OF STUDY:

The report analyzes the Digital Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Hardware Component, Software Component, Services Component); Diagnosis Type (Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis, Other Diagnosis Types); End-User (Hospitals & Clinics End-User, Clinical Laboratories End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Aidoc
• AliveCor Inc.
• Arterys Inc.
• Babylon Health
• Biofourmis
• Butterfly Network, Inc.
• Canon Medical Systems Corp.
• Digital Diagnostics Inc.
• GE HealthCare Technologies Inc.
• HeartFlow, Inc.
• iCAD Inc.
• Infermedica
• Lunit Inc.
• Medtronic plc
• Nanox Imaging Ltd.
• PathAI
• Philips Healthcare
• Qure.ai
• Siemens Healthineers AG
• Viz.ai

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Digital Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Focus on Remote and At-Home Testing Accelerates Growth of Digital Diagnostic Platforms
  • Integration of Wearables and Mobile Health Tools Expands Real-Time Diagnostic Capabilities
  • AI-Powered Image Analysis Enhances Accuracy and Speed of Diagnostic Decision-Making
  • Growing Adoption of Telehealth Services Drives Demand for Integrated Digital Diagnostic Solutions
  • Rising Demand for Chronic Disease Monitoring Sustains Innovation in Connected Diagnostic Devices
  • Surge in Demand for Early Disease Detection Throws Spotlight on Non-Invasive Digital Tools
  • Expansion of Digital Pathology Platforms Spurs Cloud-Based Diagnostic Data Management
  • Growth in Point-of-Care Testing Environments Strengthens Case for Portable Diagnostic Devices
  • Digital Integration Across Hospital Systems Drives Seamless Diagnostic Data Interoperability
  • Rising Consumer Interest in Preventive Health Drives Uptake of At-Home Diagnostic Kits
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Digital Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Digital Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Digital Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Digital Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Hospitals & Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Clinical Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Clinical Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Clinical Laboratories End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cardiology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cardiology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Cardiology Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Oncology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Oncology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Oncology Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Neurology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Neurology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Neurology Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Radiology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Radiology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Radiology Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Pathology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Pathology Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Pathology Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other Diagnosis Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• JAPAN
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• CHINA
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• EUROPE
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Digital Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Digital Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Digital Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• FRANCE
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• GERMANY
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Digital Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Digital Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Digital Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• INDIA
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Digital Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Digital Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Digital Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Digital Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Digital Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Digital Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030
• AFRICA
  • Digital Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Digital Diagnostics by Component - Hardware Component, Software Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Digital Diagnostics by Component - Percentage Breakdown of Value Sales for Hardware Component, Software Component and Services Component for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Digital Diagnostics by End-user - Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Digital Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics End-User, Clinical Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Digital Diagnostics by Diagnosis Type - Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Digital Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis and Other Diagnosis Types for the Years 2014, 2025 & 2030

IV. COMPETITION